Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on their stock buy-back program, reporting the purchase of 3,500 shares on the previous day, adding to the 37,005 shares previously acquired. This ongoing effort, indicated by the daily buy-back notification, reflects the company’s active management of its share capital.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
